<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03380403</url>
  </required_header>
  <id_info>
    <org_study_id>Faculdade de medicina do ABC</org_study_id>
    <nct_id>NCT03380403</nct_id>
  </id_info>
  <brief_title>A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients</brief_title>
  <official_title>A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Faculdade de Medicina do ABC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Faculdade de Medicina do ABC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The feet of diabetic patients continue to be an important problem in medicine. In general,
      patients with diabetic foot have some sort of amputation, especially in underserved
      populations. It is clearly necessary to develop novel treatment strategies for this worldwide
      health problem. Photodynamic therapy (PDT) , is a low cost and highly effective alternative
      treatment concerning infections avoiding amputations in the diabetic foot.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with infected diabetic foot were grouped according to the Wagner system for
      classifying foot lesions. All patients presented Wagner Grade 3 classification, with
      osteomyelitis in one or more toes. The study included only patients who had circulatory
      viability.

      For PDT treatment the fistula and/or ulcer was used as a gateway to the bone. The treated
      area (bones and fingers) was irrigated with a solution of phenothiazinium salts. After that,
      light irradiation was performed with optical fibers or led device above the wound. PDT
      treatment always in outpatients, once or twice a week.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">January 1, 2012</completion_date>
  <primary_completion_date type="Actual">January 1, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>non-randomized clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infection control</measure>
    <time_frame>every month until three months , when blood count- leucocytes reach the standard value.</time_frame>
    <description>blood count - leucocytes for infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osteomyelitis evaluation</measure>
    <time_frame>once a month, until three months, when X-ray shows bone reconstitution .</time_frame>
    <description>Radiographs were used when patients presented osteomyelitis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Diabetic Foot Infection</condition>
  <condition>Osteomyelitis</condition>
  <condition>Photo Antimicrobial Chemotherapy</condition>
  <arm_group>
    <arm_group_label>PDT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methylene blue and Photon Irradiation , every each week, until total ulcer healing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ciprofloxacin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diabetic foot patients were treated on conventional way, using antibiotics and surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PDT</intervention_name>
    <description>clinical treatment of infected diabetic foot</description>
    <arm_group_label>PDT</arm_group_label>
    <other_name>photoantimicrobial chemotherapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ciprofloxacin</intervention_name>
    <description>antibiotics and or surgical debridment</description>
    <arm_group_label>Ciprofloxacin</arm_group_label>
    <other_name>Conventional treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years old

          -  diabetes

          -  diabetic foot

          -  Wagner grade III

        Exclusion Criteria:

          -  age &lt; 18 years old

          -  non-diabetic

          -  Wagner IV and V

          -  ischemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>83 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Wainwright M, Maisch T, Nonell S, Plaetzer K, Almeida A, Tegos GP, Hamblin MR. Photoantimicrobials-are we afraid of the light? Lancet Infect Dis. 2017 Feb;17(2):e49-e55. doi: 10.1016/S1473-3099(16)30268-7. Epub 2016 Nov 22. Review.</citation>
    <PMID>27884621</PMID>
  </reference>
  <reference>
    <citation>Tardivo JP, Baptista MS, Correa JA, Adami F, Pinhal MA. Development of the Tardivo Algorithm to Predict Amputation Risk of Diabetic Foot. PLoS One. 2015 Aug 17;10(8):e0135707. doi: 10.1371/journal.pone.0135707. eCollection 2015.</citation>
    <PMID>26281044</PMID>
  </reference>
  <results_reference>
    <citation>Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016 Feb 15;473(4):347-64. doi: 10.1042/BJ20150942. Review.</citation>
    <PMID>26862179</PMID>
  </results_reference>
  <results_reference>
    <citation>Sahu K, Sharma M, Dube A, Gupta PK. Topical antimicrobial photodynamic therapy improves angiogenesis in wounds of diabetic mice. Lasers Med Sci. 2015 Sep;30(7):1923-9. doi: 10.1007/s10103-015-1784-8. Epub 2015 Jul 10.</citation>
    <PMID>26160556</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2017</study_first_submitted>
  <study_first_submitted_qc>December 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2017</study_first_posted>
  <last_update_submitted>December 26, 2017</last_update_submitted>
  <last_update_submitted_qc>December 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Faculdade de Medicina do ABC</investigator_affiliation>
    <investigator_full_name>João Paulo Tardivo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>diabetic foot</keyword>
  <keyword>Osteomyelitis</keyword>
  <keyword>PACT</keyword>
  <keyword>PDT</keyword>
  <keyword>Singlet oxygen</keyword>
  <keyword>antimicrobial</keyword>
  <keyword>diabetes</keyword>
  <keyword>Wagner scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Osteomyelitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciprofloxacin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

